Aalborg Universitet DAHANCA 28a Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC Saksoe, M.; Jensen, K.; Andersen, M.; Eriksen, J.G.; Overgaard, J. Published in: Radiotherapy and Oncology DOI (link to publication from Publisher): 10.1016/S0167-8140(19)30207-5 Creative Commons License CC BY-NC-ND 4.0 Publication date: 2019 Document Version Publisher's PDF, also known as Version of record Link to publication from Aalborg University Citation for published version (APA): Saksoe, M., Jensen, K., Andersen, M., Eriksen, J. G., & Overgaard, J. (2019). DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC. Radiotherapy and Oncology, 132(Suppl. 1), 21-22. [OC-041]. https://doi.org/10.1016/S0167-8140(19)30207-5 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research. ? You may not further distribute the material or use it for any profit-making activity or commercial gain ? You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from vbn.aau.dk on: November 25, 2020